Artivion (AORT) Change in Accured Expenses (2010 - 2026)
Artivion's (AORT) quarterly Change in Accured Expenses came in at -$8.7 million in Q1 2026, up 45.78% YoY from -$6.0 million in Q1 2025, and down 192.83% on a QoQ basis from $9.4 million in Q4 2025.
Artivion (AORT) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Artivion (AORT) has 17 years of Change in Accured Expenses data on file, last reported at -$8.7 million in Q1 2026.
- Quarterly Change in Accured Expenses rose 45.78% year-over-year to -$8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.5 million (up 258.38% YoY) and the FY2025 annual result came in at $2.2 million, down 77.02% from the prior year.
- Change in Accured Expenses declined to -$8.7 million in Q1 2026, from $9.4 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $14.7 million in Q4 2024 to a low of -$16.1 million in Q1 2025.
- A 5-year average of $487058.8 and a median of $794000.0 in 2024 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses sank 308.81% — and 2023, when it soared 436.02%.
- Tracing AORT's Change in Accured Expenses over 5 years: stood at $2.9 million in 2022, then surged by 40.26% to $4.1 million in 2023, then soared by 260.89% to $14.7 million in 2024, then slumped by 36.37% to $9.4 million in 2025, then plunged by 192.83% to -$8.7 million in 2026.
- The last three Change in Accured Expenses figures came in at -$8.7 million (Q1 2026), $9.4 million (Q4 2025), and -$967000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Artivion | 1.36 Bn | 1.28 Bn | 80.52 Mn | 4.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.33 Mn |
| Jun 30, 2026 | 4.33 Mn |
| Mar 31, 2026 | -8.70 Mn |
| Mar 31, 2026 | -8.70 Mn |
| Dec 31, 2025 | 9.38 Mn |
| Dec 31, 2025 | 9.38 Mn |
| Sep 30, 2025 | -967,000.00 |
| Sep 30, 2025 | -967,000.00 |
| Jun 30, 2025 | 9.83 Mn |
| Jun 30, 2025 | 9.83 Mn |
| Mar 31, 2025 | -16.05 Mn |
| Mar 31, 2025 | -16.05 Mn |
| Dec 31, 2024 | 14.74 Mn |
| Dec 31, 2024 | 14.74 Mn |
| Sep 30, 2024 | 794,000.00 |
| Sep 30, 2024 | 794,000.00 |
| Jun 30, 2024 | 3.19 Mn |
| Jun 30, 2024 | 3.19 Mn |
| Mar 31, 2024 | -9.22 Mn |
| Mar 31, 2024 | -9.22 Mn |